Xiaofeng Wang

3.9k total citations · 3 hit papers
90 papers, 2.9k citations indexed

About

Xiaofeng Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaofeng Wang has authored 90 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 40 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Xiaofeng Wang's work include Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (12 papers). Xiaofeng Wang is often cited by papers focused on Cancer-related molecular mechanisms research (26 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (12 papers). Xiaofeng Wang collaborates with scholars based in China, United States and Canada. Xiaofeng Wang's co-authors include Zhengjun Qiu, Kundong Zhang, Chen Huang, Jun Cao, Tao Jiang, Liping Su, Guangtao Luo, Bingya Liu, Enyong Dai and Yanan Zhao and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Xiaofeng Wang

83 papers receiving 2.9k citations

Hit Papers

Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macro... 2018 2026 2020 2023 2018 2018 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Wang China 27 2.0k 1.3k 472 459 368 90 2.9k
Fengjing Guo China 32 2.0k 1.0× 1.0k 0.8× 301 0.6× 478 1.0× 396 1.1× 111 3.7k
Liu Yang China 31 2.3k 1.2× 1.8k 1.3× 340 0.7× 397 0.9× 695 1.9× 106 3.4k
Shuying Shen China 31 2.3k 1.2× 1.4k 1.1× 275 0.6× 334 0.7× 322 0.9× 72 3.4k
Ke Wei China 26 1.9k 0.9× 1.4k 1.0× 361 0.8× 494 1.1× 411 1.1× 60 3.2k
Bin Zhu China 27 1.8k 0.9× 937 0.7× 229 0.5× 321 0.7× 264 0.7× 82 2.7k
Qiao Su China 31 1.7k 0.9× 943 0.7× 301 0.6× 248 0.5× 550 1.5× 88 2.7k
Xudong Wang China 33 2.2k 1.1× 1.4k 1.0× 323 0.7× 229 0.5× 620 1.7× 162 3.3k
Lixia Xu China 30 1.6k 0.8× 966 0.7× 286 0.6× 399 0.9× 622 1.7× 106 2.8k
Xing Qin China 27 1.6k 0.8× 901 0.7× 224 0.5× 246 0.5× 367 1.0× 65 2.3k
Lei Han China 34 2.7k 1.3× 2.0k 1.5× 219 0.5× 404 0.9× 399 1.1× 121 3.7k

Countries citing papers authored by Xiaofeng Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Wang more than expected).

Fields of papers citing papers by Xiaofeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Wang. The network helps show where Xiaofeng Wang may publish in the future.

Co-authorship network of co-authors of Xiaofeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Wang. A scholar is included among the top collaborators of Xiaofeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Wang. Xiaofeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yao, et al.. (2024). LINC01134 Directly Binds and Regulates SLC1A5 Stability to Promotes Colorectal Cancer Progression. Journal of Cancer. 15(18). 6135–6147.
2.
Wang, Zhifeng, Jiaxin Liu, Xiaoming Wang, et al.. (2024). Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis. Molecular Biomedicine. 5(1). 65–65. 3 indexed citations
3.
Yang, Jiangwei, Jingjing Wei, Shengyan Liu, et al.. (2024). stu-miR159a negatively regulates anthocyanin-specific MYB transcription factor to mediate drought stress tolerance in potato. Horticultural Plant Journal. 11(5). 1917–1929. 2 indexed citations
4.
Cheng, Jiongjia, et al.. (2024). Prediction of synergistic gemcitabine-based combination treatment through a novel tumor stemness biomarker NANOG in pancreatic cancer. RSC Medicinal Chemistry. 15(11). 3853–3861. 1 indexed citations
5.
Zheng, Xiangtao, Yihui Wang, Yu‐Ming Wang, et al.. (2024). Dissecting the mediating role of cytokines in the interaction between immune traits and sepsis: insights from comprehensive mendelian randomization. Frontiers in Immunology. 15. 1417716–1417716. 1 indexed citations
6.
Zhong, Nian‐Nian, Xiaofeng Wang, Zhuo Chen, et al.. (2023). Metformin Attenuates TGF-β1-Induced Fibrosis in Salivary Gland: A Preliminary Study. International Journal of Molecular Sciences. 24(22). 16260–16260. 6 indexed citations
7.
Wang, Haisheng, et al.. (2023). Overburdened ferroptotic stress impairs tooth morphogenesis. eLife. 12.
8.
Cheng, Jiongjia, et al.. (2022). Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets. PubMed Central. 23 indexed citations
9.
Wang, Xiaofeng, et al.. (2021). High Expression of WWP1 Associates with Tumor Progression in Papillary Thyroid Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(4). 313–323. 4 indexed citations
10.
Yang, Yuhan, Zengya Guo, Weiwei Chen, et al.. (2020). M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2. Molecular Therapy. 29(3). 1226–1238. 223 indexed citations
11.
Zhao, Wan‐Yi, et al.. (2020). Long Noncoding RNA LUADT1 Is Upregulated in Melanoma and May Sponge miR-28-5p to Upregulate RAP1B. Cancer Biotherapy and Radiopharmaceuticals. 35(4). 307–312. 9 indexed citations
12.
Liu, Ke, Huimin Gong, Dezhi Li, et al.. (2020). Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis. Toxicology and Applied Pharmacology. 410. 115363–115363. 49 indexed citations
13.
Shen, Gong-Qing, Xiaofeng Wang, Fan Wang, et al.. (2019). Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes. Journal of Biological Chemistry. 294(11). 3881–3898. 51 indexed citations
14.
Wang, Xiaofeng, Guangtao Luo, Kundong Zhang, et al.. (2018). Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis. Cancer Research. 78(16). 4586–4598. 580 indexed citations breakdown →
15.
Zhou, Haoyu, et al.. (2017). LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer. Cancer Gene Therapy. 25(1-2). 39–46. 24 indexed citations
17.
Wang, Jian, Yongli Li, Xiaofeng Wang, & Chuanlu Jiang. (2012). Ursolic Acid Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Cell Lines U251 by Suppressing TGF‐β1/miR‐21/PDCD4 Pathway. Basic & Clinical Pharmacology & Toxicology. 111(2). 106–112. 63 indexed citations
18.
Jin, Heiying, et al.. (2011). [Expression pattern and clinical significance of hairy enhancer of split 1 in colorectal cancer].. PubMed. 91(41). 2891–4. 1 indexed citations
19.
Li, Qing, et al.. (2010). [Effect of integrin-linked kinase on the growth of prostate cancer in nude mice].. PubMed. 42(4). 374–80. 1 indexed citations
20.
Zhang, Qi, et al.. (2010). The association of two SNPs on chromosome 9p21 with myocardial infarction in Chinese Hans.. Shandong yiyao. 50(5). 4–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026